Vivian Hasbrook
Psychiatry · Norman, OKNPI 1225101215
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 438 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,328, 3.2 times the $739 reported in 2019. Among psychiatry clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 438 payments — averaging $26.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$2K
- Johnson & Johnson$2K
- Alkermes, Inc.$2K
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$964
- Otsuka America Pharmaceutical, Inc.$756
- plus $2K from 15 others
What the payments were for
- Food & beverage$11,792100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 73 | $2,341 |
| Johnson & Johnson | 70 | $1,929 |
| Alkermes, Inc. | 56 | $1,706 |
| AbbVie(2 entities) | 88 | $1,650 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 36 | $964 |
| Otsuka America Pharmaceutical, Inc. | 23 | $756 |
| Indivior Inc. | 28 | $466 |
| Vanda Pharmaceuticals Inc. | 11 | $455 |
| Lundbeck LLC | 20 | $430 |
| E.r. Squibb & Sons, L.L.C. | 10 | $346 |
| Acadia Pharmaceuticals Inc | 10 | $198 |
| Neurocrine Biosciences, Inc. | 2 | $162 |
| Novo Nordisk | 1 | $116 |
| Noven Pharmaceuticals, Inc. | 1 | $108 |
| Sunovion Pharmaceuticals Inc. | 3 | $60 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Eisai Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $16 |
| Bioxcel Therapeutics, Inc. | 1 | $15 |
| Noven Therapeutics, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$1,460
- LYBALVI$872
- INVEGA SUSTENNA$835
- CAPLYTA$566
- VRAYLAR$566
- Austedo XR$469
- UZEDY$370
- ARISTADA INITIO$365
- AUSTEDO$330
- COBENFY$234
- SPRAVATO$218
- INVEGA TRINZA$217
- Fanapt$216
- RYBELSUS$116
- INGREZZA$113
- Xelstrym$108
- NUPLAZID$106
How this compares
$11,792 in reported general payments places this provider in the 95th percentile of 328 psychiatry providers in Oklahoma.
Other psychiatry in Norman
- Julia IrwinNorman$16K
- Richard HartmanNorman$15K
- Uzma ZaidiNorman$11K
- Jack GrayNorman$9K
- Joseph RippergerNorman$6K
- Keenan SmartNorman$6K
- Robert MortonAda$1.9M
- Sarah LandTulsa$287K
- Willis HollowayOklahoma City$92K
- Adonis Al BotrosOklahoma City$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.